# FDA Inspection 1233401 - Detrex Corporation - March 11, 2024

Source: https://www.keypedia.com/records/fda_inspections/detrex-corporation/0605dcba-015a-4fa0-bc0d-85fa2c234b4f
Source feed: FDA_Inspections

> FDA Inspection 1233401 for Detrex Corporation on March 11, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1233401
- Company Name: Detrex Corporation
- Inspection Date: 2024-03-11
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1174968 - 2022-07-06](https://www.keypedia.com/records/fda_inspections/detrex-corporation/a29b3aef-4a57-4a6b-8efe-dd51457b4e9e)
- [FDA Inspection 1014048 - 2017-05-11](https://www.keypedia.com/records/fda_inspections/detrex-corporation/58241cb2-2740-4282-a5b5-ef5f520bdbd8)

Company: https://www.keypedia.com/companies/detrex-corporation/4f1cb0f1-0c23-421a-a7aa-0d55ae82bdb0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c